DE60211632D1 - Verwendung von Cyclotetrasaccharide zur Erhöhung der "Aktiven-Sauerstoff-Eliminierenden-Aktivität" - Google Patents

Verwendung von Cyclotetrasaccharide zur Erhöhung der "Aktiven-Sauerstoff-Eliminierenden-Aktivität"

Info

Publication number
DE60211632D1
DE60211632D1 DE60211632T DE60211632T DE60211632D1 DE 60211632 D1 DE60211632 D1 DE 60211632D1 DE 60211632 T DE60211632 T DE 60211632T DE 60211632 T DE60211632 T DE 60211632T DE 60211632 D1 DE60211632 D1 DE 60211632D1
Authority
DE
Germany
Prior art keywords
cyclotetrasaccharides
active
increase
eliminating activity
oxygen eliminating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60211632T
Other languages
English (en)
Other versions
DE60211632T2 (de
Inventor
Kazuyuki Oku
Michio Kubota
Shigeharu Fukuda
Toshio Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Publication of DE60211632D1 publication Critical patent/DE60211632D1/de
Application granted granted Critical
Publication of DE60211632T2 publication Critical patent/DE60211632T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/10—Washing or bathing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
DE60211632T 2001-11-20 2002-11-19 Verwendung von Cyclotetrasaccharide zur Erhöhung der "Aktiven-Sauerstoff-Eliminierenden-Aktivität" Expired - Lifetime DE60211632T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001355273A JP4397142B2 (ja) 2001-11-20 2001-11-20 活性酸素消去能低減抑制剤
JP2001355273 2001-11-20

Publications (2)

Publication Number Publication Date
DE60211632D1 true DE60211632D1 (de) 2006-06-29
DE60211632T2 DE60211632T2 (de) 2007-05-10

Family

ID=19166999

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60211632T Expired - Lifetime DE60211632T2 (de) 2001-11-20 2002-11-19 Verwendung von Cyclotetrasaccharide zur Erhöhung der "Aktiven-Sauerstoff-Eliminierenden-Aktivität"

Country Status (6)

Country Link
US (2) US20030108593A1 (de)
EP (1) EP1321148B1 (de)
JP (1) JP4397142B2 (de)
KR (1) KR100943559B1 (de)
DE (1) DE60211632T2 (de)
TW (1) TWI256292B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4397142B2 (ja) * 2001-11-20 2010-01-13 株式会社林原生物化学研究所 活性酸素消去能低減抑制剤
US20050267067A1 (en) * 2002-08-30 2005-12-01 Kazuyuki Oku Radical reaction inhibitors, method for inhibition of radical reactions, and use thereof
JP4702745B2 (ja) * 2003-07-18 2011-06-15 株式会社林原生物化学研究所 ミネラル吸収促進剤及びその用途
WO2005027944A1 (en) 2003-09-22 2005-03-31 Purecell Technologies Inc. Oral compositions and route of administration for the delivery of a thylakoid extract
US8941668B2 (en) 2004-06-25 2015-01-27 Nvidia Corporation Method and system for a scalable discrete graphics system
US8411093B2 (en) 2004-06-25 2013-04-02 Nvidia Corporation Method and system for stand alone graphics independent of computer system form factor
KR20070095338A (ko) * 2004-12-24 2007-09-28 가부시끼가이샤 하야시바라 세이부쓰 가가꾸 겐꾸조 간기능 개선제
JP4766653B2 (ja) * 2005-01-28 2011-09-07 株式会社林原生物化学研究所 眼科用医薬組成物
KR100689715B1 (ko) * 2005-09-22 2007-03-08 양건태 김치제조방법 및 이를 위한 김치포장방법과 그 포장체
EP2117356B1 (de) * 2007-01-17 2012-07-04 Fytexia Antioxidans-nahrungsmittelzusammensetzung, die früchte und gemüse enthält, verfahren zu ihrer herstellung und verwendung der zusammensetzung
JP4503087B2 (ja) 2008-08-19 2010-07-14 稔 菅野 糖度向上、糖成分調整および呈味調整に関する素材、方法および果実・野菜類
CN102325519B (zh) 2009-02-23 2014-10-29 荷兰联合利华有限公司 处理老化皮肤迹象的可食用组合物
WO2012095746A2 (en) 2011-01-11 2012-07-19 Capsugel Belgium Nv New hard capsules
JP7136765B2 (ja) 2017-03-24 2022-09-13 株式会社林原 オートファジー誘導剤とその用途
BR112019021396A2 (pt) 2017-04-14 2020-04-28 Capsugel Belgium Nv processo para fabricação de pululano
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊
CN108617757A (zh) * 2018-03-27 2018-10-09 荔浦县万家兴果蔬专业合作社 一种葡萄的保鲜方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5231019B2 (de) * 1973-10-16 1977-08-12
US5969214A (en) * 1990-06-11 1999-10-19 Calgene, Inc. Glycogen biosynthetic enzymes in plants
JP2823706B2 (ja) * 1991-02-07 1998-11-11 三共株式会社 品質安定化剤
JP2933774B2 (ja) * 1991-12-19 1999-08-16 七郎 庭野 葉類加工食品及びその製法
JP3212706B2 (ja) * 1992-08-05 2001-09-25 日本食品化工株式会社 飲食物
JP3168550B2 (ja) * 1992-12-02 2001-05-21 株式会社林原生物化学研究所 脱水剤およびそれを用いる含水物の脱水方法並びにその方法で得られる脱水物品
JPH08143466A (ja) * 1994-11-15 1996-06-04 Sanki Shoji Kk 天然抗酸化剤および活性酸素消去剤
US5786196A (en) * 1995-06-12 1998-07-28 The United States Of America As Represented By The Secretary Of Agriculture Bacteria and enzymes for production of alternan fragments
EP0794259B1 (de) * 1996-03-04 2004-10-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Herstellung einer Trehalulose enthaltende Polysaccharidzusammensetzung.
TW466116B (en) * 1997-03-04 2001-12-01 Hayashibara Biochem Lab Reduction inhibitory agent for active-oxygen eliminating activity, method for inhibiting the reduction of said activity, and composition containing said agent
JPH10279458A (ja) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The 組成物
JP4295840B2 (ja) * 1997-12-09 2009-07-15 株式会社林原生物化学研究所 血行改善剤
JP3364442B2 (ja) * 1998-12-25 2003-01-08 日本食品化工株式会社 退色防止剤、活性酸素消去剤、飲食品の退色防止法及び飲食品の活性酸素消去能を増強させる方法
US6536181B1 (en) * 1999-01-13 2003-03-25 Won Kee Hong Composite retaining wall and construction method for underground structure
JP4919198B2 (ja) * 2000-05-22 2012-04-18 株式会社林原生物化学研究所 α−イソマルトシル転移酵素とその製造方法並びに用途
TWI312369B (en) * 2000-08-01 2009-07-21 Hayashibara Biochem Lab A-isomaltosylglucosaccharide synthase,process for producing the same and use thereof
AU781975B2 (en) * 2000-09-14 2005-06-23 Hayashibara Co., Ltd Pharmaceutical composition for ophthalmic use
US6562600B1 (en) * 2001-06-25 2003-05-13 The United States Of America As Represented By The Secretary Of Agriculture Production of cyclic alternan tetrasaccharides from oligosaccharide substrates
KR20030016706A (ko) * 2001-08-21 2003-03-03 주식회사 가릭솔 오동성분을 주원료로 하는 활성산소 제거제 및 그 제조방법
JP4397142B2 (ja) * 2001-11-20 2010-01-13 株式会社林原生物化学研究所 活性酸素消去能低減抑制剤
US20050065030A1 (en) * 2001-11-20 2005-03-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reduction inhibitory agent for active oxygen eliminating activity

Also Published As

Publication number Publication date
TW200300331A (en) 2003-06-01
TWI256292B (en) 2006-06-11
US20050123671A1 (en) 2005-06-09
JP4397142B2 (ja) 2010-01-13
KR20030041813A (ko) 2003-05-27
US20030108593A1 (en) 2003-06-12
JP2003160495A (ja) 2003-06-03
DE60211632T2 (de) 2007-05-10
EP1321148A1 (de) 2003-06-25
KR100943559B1 (ko) 2010-02-22
EP1321148B1 (de) 2006-05-24

Similar Documents

Publication Publication Date Title
DE69841307D1 (de) Verwendung von peroxiden zur bekämpfung der haarigen warzenerkrankung
DE60211632D1 (de) Verwendung von Cyclotetrasaccharide zur Erhöhung der "Aktiven-Sauerstoff-Eliminierenden-Aktivität"
ATE401309T1 (de) Verwendung von 2-fuoro-3-ketoestern zur herstellung von 3-fuoro-6,7,8,9-tetrahydro-4h- pyrimidoä1,2-aüpyrimidin-4-onen
DE60217432D1 (de) Verwendungen von Kohlenstofffasern
DE60136181D1 (de) 3'-prodrugs von 2'-deoxy-beta-l-nukleosiden
DE69812901D1 (de) Katalytische herstellung von pentafluorpropenen
DE60002526D1 (de) Herstellung von Tricyclodecandicarbaldehyd, Pentacyclopentadecandicarbaldehyd und der entsprechenden Dimethanole
ATE309987T1 (de) Substituierte benzamide und ihre verwendung als immunmodulatoren
DE69827788D1 (de) Herstellung von hydroxyurethanen
ATE301703T1 (de) Verwendung von zusammensetzungen zur textilpflege
ATE396719T1 (de) Verwendung von (z)-2-cyano-3-hydroxy-but-2- ensäure-(4'-trifluoromethylphenyl)-amid zur behandlung der multiplen sklerose
IT1294572B1 (it) Dispositivo filtrante per acquari, del tipo da appendere all'esterno dell'acquario e comunemente conosciuto come"power filter"o"hang on
DE60130661D1 (de) Verwendung der 13-cis retinsäure zur behandlung von emphysemen
DE60030861D1 (de) Verwendung von escitalopram zur Behandlung von generalisierten Angstzuständen
DE50014613D1 (de) Kosmetische verwendung von ruckstanden aus der weinherstellung
DE69928820D1 (de) Akt zusammensetzungen zur steigerung des überlebens von kardiomyozyten
DE50103536D1 (de) Verwendung von kationischen Zubereitungen
DE69900514T2 (de) Herstellung von Polyalkylsilsesquioxan-Teilchen
DE69922558D1 (de) Herstellung von Aluminiumoxid
DE60117122D1 (de) Verwendung von mirtazapin zur behandlung von schlafstörungen
ATE303153T1 (de) Ibandroinsäure zur förderung der osseointegration der endoprothesen
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
DE60007111D1 (de) Herstellung von ausgewählten fluorolefinen
DE50011084D1 (de) Verwendung von azolen zur prävention von strahlen-induziertem hautkrebs
DE50006852D1 (de) Verwendung von nanoskaligen deodorantien

Legal Events

Date Code Title Description
8364 No opposition during term of opposition